KCM
HCAT icon

Kennedy Capital Management’s Health Catalyst HCAT Stock Holding History

Kennedy Capital Management’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$647K Sell
509,782
-455,007
-47% -$856K 0.01% 509
2025
Q4 		$2.31M Buy
964,789
+2,108
+0.2% +$5.76K 0.05% 411
2025
Q3 		$2.74M Sell
962,681
-107,514
-10% -$368K 0.06% 400
2025
Q2 		$4.03M Sell
1,070,195
-58,333
-5% -$229K 0.1% 330
2025
Q1 		$5.11M Sell
1,128,528
-762,472
-40% -$4.03M 0.12% 286
2024
Q4 		$13.4M Buy
1,891,000
+565,445
+43% +$4.5M 0.3% 84
2024
Q3 		$10.8M Buy
1,325,555
+50,711
+4% +$366K 0.24% 125
2024
Q2 		$8.15M Buy
1,274,844
+108,842
+9% +$699K 0.17% 201
2024
Q1 		$8.78M Buy
+1,166,002
New +$10.6M 0.18% 202

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
CF
CDC Financial Chicago, Illinois $157M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $288M AUM 44.06% 1-Year Est. Return
PVM
Palogic Value Management Dallas, Texas $237M AUM 5.37% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Kennedy Capital Management's HCAT Position: Q1 2026 in Review

Kennedy Capital Management reduced its Health Catalyst (HCAT) stake by 47% in Q1 2026, selling an estimated $856K and leaving 509,782 shares worth $647K. The position accounts for 0.01% of the portfolio, ranked #509.

Kennedy Capital Management first reported a position in HCAT in Q1 2024 and has held it in 9 quarters since. The position peaked at $13.4M in Q4 2024. 130 funds tracked by Wall St. Rank hold HCAT as of Q1 2026.

  • Kennedy Capital Management held 509,782 shares of Health Catalyst worth $647K as of Q1 2026.
  • Kennedy Capital Management sold 455,007 Health Catalyst shares in Q1 2026, an estimated $856K.
  • Health Catalyst made up 0.01% of Kennedy Capital Management's portfolio in Q1 2026, its #509 holding.
  • Kennedy Capital Management first reported a position in Health Catalyst in Q1 2024 and has held it in 9 quarters since.
  • Kennedy Capital Management's Health Catalyst position peaked at $13.4M in Q4 2024.
  • 130 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2026.

Based on Kennedy Capital Management's 13F filing for Q1 2026, filed 13 May 2026.